Evaluation of NV556, a Novel Cyclophilin Inhibitor, as a Potential Antifibrotic Compound for Liver FibrosisSonia Serrano, Ramin Massoumi, Giuseppe Mazza et al.|Cells|2019Cited by 21
Cyclophilin Inhibitor NV556 Reduces Fibrosis and Hepatocellular Carcinoma Development in Mice With Non-Alcoholic SteatohepatitisJoseph Kuo, Philippe Gallay, Sonia Serrano et al.|Frontiers in Pharmacology|2019Cited by 20
Novel Cyclophilin Inhibitor Decreases Cell Proliferation and Tumor Growth in Models of Hepatocellular CarcinomaSonia Serrano, Ramin Massoumi, Michele Tavecchio et al.|Cancers|2021Cited by 11
Synergistic Effects of Sanglifehrin-Based Cyclophilin Inhibitor NV651 with Cisplatin in Hepatocellular CarcinomaSonia Serrano, Ramin Massoumi, Philippe Gallay et al.|Cancers|2022Cited by 5